Landscapes / Targets
MC1R
2 drugs act on MC1R, in 2 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs2
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Dec 2027Phase 3 trial completes | |||
| Next date | Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | EPP, XLP | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Dec 2027Phase 1/2 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Recurrent Melanoma (Skin), Metastatic Melanoma and 2 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 2 of 2 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026